Materials for clinical trials must be fit for their intended use
Pharmaceutical products including materials for clinical trials must be fit for their intended use, comply with the relevant requirements and must not place patients at risk due to inadequate safety, quality or efficacy.
To achieve this quality objective in a reliable manner, the team at ABF has implemented a comprehensive quality management system in which all quality assurance measures are based on Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP).
ABF Manufacturer’s Authorisation 2015 / ABF GMP Certificate 2015
- Comprehensive QM System
- GMP, GCP and ICH Implemented
We operate to the highest of audited quality standards.